experspadmin

Sphingosine-1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis
Neurology

Sphingosine-1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis

clinical topic updates
By Eric C. Klawiter, MD, MSc
Real-World Effectiveness of First-line Treatment in Relapsing-Remitting Multiple Sclerosis
Neurology

Real-World Effectiveness of First-line Treatment in Relapsing-Remitting Multiple Sclerosis

clinical topic updates
By Robert A. Bermel, MD, MBA
Expert Perspectives in Chronic Graft-versus-Host Disease to Cover Key Topics in Chronic Graft-versus-Host Disease Treatment
Oncology

Expert Perspectives in Chronic Graft-versus-Host Disease to Cover Key Topics in Chronic Graft-versus-Host Disease Treatment

expert perspectives
By Corey Cutler, MD, MPH, FRCP(C); Daniel R. Couriel, MD, MS; Sergio A. Giralt, MD
Initial Approach to Newly Diagnosed Patients With Chronic Myeloid Leukemia
Oncology

Initial Approach to Newly Diagnosed Patients With Chronic Myeloid Leukemia

expert roundtables
By Gabriela S. Hobbs, MD; Mark J. Levis, MD, PhD; Neil P. Shah, MD, PhD
Effectiveness of Treatments for Chronic Myeloid Leukemia: Raising the Bar
Oncology

Effectiveness of Treatments for Chronic Myeloid Leukemia: Raising the Bar

expert roundtables
By Gabriela S. Hobbs, MD; Mark J. Levis, MD, PhD; Neil P. Shah, MD, PhD
Load More